Recent advances in cerebral cavernous malformation research
Cerebral cavernous malformations (CCM) are manifested by microvascular lesions characterized by leaky endothelial cells with minimal intervening parenchyma predominantly in the central nervous system predisposed to hemorrhagic stroke, resulting in focal neurological defects. Till date, three proteins are implicated in this condition: CCM1 (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10). These multi-domain proteins form a protein complex via CCM2 that function as a docking site for the CCM signaling complex, which modulates many signaling pathways. Defects in the formation of this signaling complex have been shown to affect a wide range of cellular processes including cell-cell contact stability, vascular angiogenesis, oxidative damage protection and multiple biogenic events. In this review we provide an update on recent advances in structure and function of these CCM proteins, especially focusing on the signaling cascades involved in CCM pathogenesis and the resultant CCM cellular phenotypes in the past decade.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
Vessel plus - 2(2018) vom: 22. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Padarti, Akhil [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 30.09.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.20517/2574-1209.2018.34 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM299725111 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299725111 | ||
| 003 | DE-627 | ||
| 005 | 20231225100951.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.20517/2574-1209.2018.34 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0999.xml |
| 035 | |a (DE-627)NLM299725111 | ||
| 035 | |a (NLM)31360916 | ||
| 035 | |a (PII)21 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Padarti, Akhil |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent advances in cerebral cavernous malformation research |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Cerebral cavernous malformations (CCM) are manifested by microvascular lesions characterized by leaky endothelial cells with minimal intervening parenchyma predominantly in the central nervous system predisposed to hemorrhagic stroke, resulting in focal neurological defects. Till date, three proteins are implicated in this condition: CCM1 (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10). These multi-domain proteins form a protein complex via CCM2 that function as a docking site for the CCM signaling complex, which modulates many signaling pathways. Defects in the formation of this signaling complex have been shown to affect a wide range of cellular processes including cell-cell contact stability, vascular angiogenesis, oxidative damage protection and multiple biogenic events. In this review we provide an update on recent advances in structure and function of these CCM proteins, especially focusing on the signaling cascades involved in CCM pathogenesis and the resultant CCM cellular phenotypes in the past decade | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cerebral cavernous malformation | |
| 650 | 4 | |a angiogenesis | |
| 650 | 4 | |a cellular function | |
| 650 | 4 | |a cerebral cavernous malformation signaling complex | |
| 650 | 4 | |a endothelial cells | |
| 650 | 4 | |a function domain | |
| 650 | 4 | |a microvessel lesions | |
| 650 | 4 | |a motif | |
| 650 | 4 | |a protein structure | |
| 700 | 1 | |a Zhang, Jun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vessel plus |d 2017 |g 2(2018) vom: 22. |w (DE-627)NLM285496018 |x 2574-1209 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2018 |g day:22 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20517/2574-1209.2018.34 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2018 |b 22 | ||